Search

Your search keyword '"Michel Beaugrand"' showing total 250 results

Search Constraints

Start Over You searched for: Author "Michel Beaugrand" Remove constraint Author: "Michel Beaugrand"
250 results on '"Michel Beaugrand"'

Search Results

1. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B

2. Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report

Catalog

Books, media, physical & digital resources

3. Transient elastography in non-alcoholic fatty liver disease

4. Perspective on This Article from Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis

5. Data from Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis

6. Supplementary Table 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

7. Supplementary Figures 1 - 2 from Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

8. Supplementary Figure 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

9. Data from Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

10. Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement

11. Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan

12. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies

13. Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease

14. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis

15. Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis

16. High Frequency of X Chromosome Abnormalities in Women With Short Stature and Elevated Liver Enzymes

17. Histopathologic Comparison of Monopolar versus No-Touch Multipolar Radiofrequency Ablation to Treat Hepatocellular Carcinoma within Milan Criteria

18. Diaphragmatic necrosis after radiofrequency ablation of hepatocellular carcinoma: A successful surgical repair

19. Stakeholder perspectives on European priorities for comprehensive liver cancer control: a conjoint analysis

20. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis

21. Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report

22. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results

23. Résultats du traitement par radiofréquence du carcinome hépatocellulaire chez le cirrhotique âgé de 75 ans et plus

24. Facteur de risque et dépistage du carcinome hépatocellulaire

25. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities

27. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study

28. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

29. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

30. Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients

31. Chemokine RANTES Promoter Dimorphisms and Hepatocellular Carcinoma Occurrence in Patients with Alcoholic or Hepatitis C Virus–Related Cirrhosis

32. Do Genetic Variations in Antioxidant Enzymes Influence the Course of Hereditary Hemochromatosis?

33. Telomerase gene mutations are associated with cirrhosis formation

34. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis

35. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis

36. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis

37. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis

38. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: A prospective magnetic resonance imaging and histological study

39. Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure

40. Antimitochondrial antibodies in patients with chronic hepatitis C

41. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis

42. Large (≥5.0-cm) HCCs: Multipolar RF Ablation with Three Internally Cooled Bipolar Electrodes—Initial Experience in 26 Patients

43. Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome

44. Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities

45. Influence de la proximité des gros vaisseaux sur les résultats du traitement des carcinomes hépato-cellulaires par radiofréquence : une étude contrôlée

47. Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis

48. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis - ANRS HC EP07 study*

49. Genetic Polymorphisms in Antioxidant Enzymes Modulate Hepatic Iron Accumulation and Hepatocellular Carcinoma Development in Patients with Alcohol-Induced Cirrhosis

50. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis